Biotech News
Terns Pharmaceuticals to Participate in Upcoming March Investor Conferences
ir.ternspharma.com2026-05-06 14:56 EST
FOSTER CITY, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage oncology company, today announced that members of senior management will be participating in the following upcoming investor conferences in March.